Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Khazaeinia, T; Ramsey, AA; Tam, YK
   The effects of exercise on the pharmacokinetics of drugs
   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
   
   T. Khazaeinia et al., "The effects of exercise on the pharmacokinetics of drugs", J PHARM P S, 3(3), 2000, pp. 292-302
2. Wollmer, P; Backstrom, K; Zhao, H; Nilsson, PG; Jonson, B
   Surface active agents as enhancers of alveolar absorption
   PHARMACEUTICAL RESEARCH
   
   P. Wollmer et al., "Surface active agents as enhancers of alveolar absorption", PHARM RES, 17(1), 2000, pp. 38-41
3. Iversen, ET; Sorensen, T; Heckscher, T; Jensen, JI
   Effect of terbutaline on exercise capacity and pulmonary function in patients with chronic obstructive pulmonary disease
   LUNG
   
   E.T. Iversen et al., "Effect of terbutaline on exercise capacity and pulmonary function in patients with chronic obstructive pulmonary disease", LUNG, 177(4), 1999, pp. 263-271
4. Wildhaber, JH; Devadason, SG; Wilson, JM; Roller, C; Lagana, T; Borgstrom, L; LeSouef, PN
   Lung deposition of budesonide from Turbuhaler in asthmatic children
   EUROPEAN JOURNAL OF PEDIATRICS
   
   J.H. Wildhaber et al., "Lung deposition of budesonide from Turbuhaler in asthmatic children", EUR J PED, 157(12), 1998, pp. 1017-1022
5. BJERMER L; LARSSON L
   LONG-ACTING BETA(2)-AGONISTS - HOW ARE THEY USED IN AN OPTIMAL WAY
   Respiratory medicine
   
   L. Bjermer e L. Larsson, "LONG-ACTING BETA(2)-AGONISTS - HOW ARE THEY USED IN AN OPTIMAL WAY", Respiratory medicine, 91(10), 1997, pp. 587-591
6. GROVE A; LIPWORTH BJ; REID P; SMITH RP; RAMAGE L; INGRAM CG; JENKINS RJ; WINTER JH; DHILLON DP
   EFFECTS OF REGULAR SALMETEROL ON LUNG-FUNCTION AND EXERCISE CAPACITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE AIRWAYS DISEASE
   Thorax
   
   A. Grove et al., "EFFECTS OF REGULAR SALMETEROL ON LUNG-FUNCTION AND EXERCISE CAPACITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE AIRWAYS DISEASE", Thorax, 51(7), 1996, pp. 689-693
7. MOLER FW; JOHNSON CE; VANLAANEN C; PALMISANO JM; NASR SZ; AKINGBOLA O
   CONTINUOUS VERSUS INTERMITTENT NEBULIZED TERBUTALINE - PLASMA-LEVELS AND EFFECTS
   American journal of respiratory and critical care medicine
   
   F.W. Moler et al., "CONTINUOUS VERSUS INTERMITTENT NEBULIZED TERBUTALINE - PLASMA-LEVELS AND EFFECTS", American journal of respiratory and critical care medicine, 151(3), 1995, pp. 602-606
8. JAESCHKE R; GUYATT GH; WILLAN A; COOK D; HARPER S; MORRIS J; RAMSDALE H; HADDON R; NEWHOUSE M
   EFFECT OF INCREASING DOSES OF BETA-AGONISTS ON SPIROMETRIC PARAMETERS, EXERCISE CAPACITY, AND QUALITY-OF-LIFE IN PATIENTS WITH CHRONIC AIR-FLOW LIMITATION
   Thorax
   
   R. Jaeschke et al., "EFFECT OF INCREASING DOSES OF BETA-AGONISTS ON SPIROMETRIC PARAMETERS, EXERCISE CAPACITY, AND QUALITY-OF-LIFE IN PATIENTS WITH CHRONIC AIR-FLOW LIMITATION", Thorax, 49(5), 1994, pp. 479-484
9. JAESCHKE R; GUYATT GH; COOK D; MORRIS J; WILLAN A; MCILROY W; HARPER S; RAMSDALE H; HADDON R; FITZGERALD MJ; NEWHOUSE M
   THE EFFECT OF INCREASING DOSES OF BETA-AGONISTS ON AIR-FLOW IN PATIENTS WITH CHRONIC AIR-FLOW LIMITATION
   Respiratory medicine
   
   R. Jaeschke et al., "THE EFFECT OF INCREASING DOSES OF BETA-AGONISTS ON AIR-FLOW IN PATIENTS WITH CHRONIC AIR-FLOW LIMITATION", Respiratory medicine, 87(6), 1993, pp. 433-438